title: Foscarnet therapy for cytomegalovirus infection after allogeneic bone marrow transplantation.
authors.affiliation: Department of Medicine, Royal Marsden Hospital, Sutton, Surrey, United Kingdom.
authors.forename: J
authors.initials: J
authors.lastname: Chang
authors.forename: R
authors.initials: R
authors.lastname: Powles
authors.forename: S
authors.initials: S
authors.lastname: Singhal
authors.forename: N
authors.initials: N
authors.lastname: Paton
authors.forename: B
authors.initials: B
authors.lastname: Jameson
authors.forename: J
authors.initials: J
authors.lastname: Treleaven
authors.forename: J
authors.initials: J
authors.lastname: Mehta
mesh_terms: D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000821:virology; D017245:Foscarnet / Q000627:therapeutic use*; D006801:Humans; D011446:Prospective Studies; D014184:Transplantation, Homologous
chemical_list: D017245:Foscarnet